Skip Nav Destination
Issues
June 2020
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
ISSN 2296-5270
EISSN 2296-5262
In this Issue
Journal Name Change
Vol. 1-36 (1978-2013) were published under the journal's former title Onkologie.
Oncology Research and Treatment 2020, Vol. 43, No. 6
Editorial
Oncology Research and Treatment 2020: Past, Present, and Future
Subject Area:
Oncology
Oncol Res Treat (2020) 43 (6): 259–261.
https://doi.org/10.1159/000508227
Community-Acquired Respiratory Viruses in Oncology: Lessons to Be Learnt from the SARS-CoV-2 Pandemic
Topic Article Package:
Topic Article Package: Coronavirus (COVID-19)
Subject Area:
Oncology
Oncol Res Treat (2020) 43 (6): 262–263.
https://doi.org/10.1159/000508452
Research Article
Golgi Alpha-Mannosidase II as a Novel Biomarker Predicts Prognosis in Clear Cell Renal Cell Carcinoma
Subject Area:
Oncology
Oncol Res Treat (2020) 43 (6): 264–275.
https://doi.org/10.1159/000505931
Propensity Score Matching Analysis for the Role of Surgery in Small Cell Lung Cancer
Subject Area:
Oncology
Oncol Res Treat (2020) 43 (6): 276–288.
https://doi.org/10.1159/000506867
Response to Checkpoint Inhibition in Non-Small Cell Lung Cancer with Molecular Driver Alterations
Subject Area:
Oncology
Diego Kauffmann-Guerrero; Amanda Tufman; Kathrin Kahnert; Benjamin Alexander Bollmann; Simone Reu; Zulfiya Syunyaeva; Christian Schneider; Farkhad Manapov; Rudolf M. Huber; Heiko Golpon
Oncol Res Treat (2020) 43 (6): 289–298.
https://doi.org/10.1159/000506842
Review Article
Docetaxel Rechallenge in Patients with Metastatic Prostate Cancer: A Comprehensive Review
Subject Area:
Oncology
Oncol Res Treat (2020) 43 (6): 299–306.
https://doi.org/10.1159/000506693
Implications of SARS-CoV-2 Infection and COVID-19 Crisis on Clinical Cancer Care: Report of the University Cancer Center Hamburg
Topic Article Package:
Topic Article Package: Coronavirus (COVID-19)
Subject Area:
Oncology
Katja C. Weisel; Andrea Morgner-Miehlke; Cordula Petersen; Walter Fiedler; Andreas Block; Philippe Schafhausen; Johannes K. Knobloch; Carsten Bokemeyer
Oncol Res Treat (2020) 43 (6): 307–313.
https://doi.org/10.1159/000508272
The Biology of Myxofibrosarcoma: State of the Art and Future Perspectives
Subject Area:
Oncology
Oncol Res Treat (2020) 43 (6): 314–322.
https://doi.org/10.1159/000507334
PharmaForum
CLL: Ibrutinib bei IgHV-Status unmutiert
Subject Area:
Oncology
Oncol Res Treat (2020) 43 (6): 323.
https://doi.org/10.1159/000508895
PharmaNews
Subject Area:
Oncology
Oncol Res Treat (2020) 43 (6): 324.
https://doi.org/10.1159/000508896
PharmaNews
Subject Area:
Oncology
Oncol Res Treat (2020) 43 (6): 325–326.
https://doi.org/10.1159/000508897
Society Bulletins: COVID-19: Patienten mit aktiver Krebserkrankung testen
Subject Area:
Oncology
Oncol Res Treat (2020) 43 (6): 328–332.
https://doi.org/10.1159/000508597
